4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-059291
Director sold 6,000 shares at an average $47.69 ($286,135)
- Director acquired 6,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GRIFFIN MICHELLE RENEE Director | 2020-11-16 | Option exercise | +6,000 | $7.80 | $46,800 | 6,000 | D |
| GRIFFIN MICHELLE RENEE Director | 2020-11-16 | Sale | −5,021 | $47.57 | $238,849 | 979 | D |
| GRIFFIN MICHELLE RENEE Director | 2020-11-16 | Sale | −979 | $48.30 | $47,286 | 0 | D |
| Derivatives | |||||||
| GRIFFIN MICHELLE RENEE Director | 2020-11-16 | Option exercise · Stock Option (Right to Buy) | −6,000 | 107,000 | D | ||
| Open-market sales · 6,000 sh · avg $47.69 · $286,135 | |||||||
Loading xslF345X03/doc4.xml…